Literature DB >> 8324218

Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII.

T Hashiguchi1, M Saito, E Morishita, T Matsuda, A Ichinose.   

Abstract

A genomic DNA obtained from a female patient with complete b-subunit deficiency was examined by Southern blotting analysis and in vitro amplification. Nucleotide sequence analysis showed that adenosine-4161 at the acceptor splice junction of intron A/exon II was deleted in half of the amplified DNAs, resulting in a loss of the obligatory AG splicing sequence. The absence of adenosine-4161 was confirmed by cleavage with TaqI endonuclease of the amplified DNAs. Moreover, sequence analysis showed that guanosine-11499 coding for Cys 430 (TGC) in exon VIII was replaced by thymidine in half of the amplified DNAs, resulting in an amino acid change to Phe (TTC) and the destruction of a disulfide bond in the seventh Sushi domain. This mutation was also confirmed by cleavage with MboII endonuclease. Thus, the proband turned out to be a compound heterozygote of two separate defective alleles. Although half of the amplified DNAs for exon VIII of her daughter or son were cleaved by MboII, those for intron A were not cleaved by TaqI. The replacement of guanosine-11499 by thymidine in their exon VIII has also been confirmed by sequence analysis, indicating that they are heterozygous for one normal and one defective allele.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324218

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.

Authors:  Akitada Ichinose
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

2.  Comprehensive Proteome Profiling of Platelet Identified a Protein Profile Predictive of Responses to An Antiplatelet Agent Sarpogrelate.

Authors:  Hangyeore Lee; Sehyun Chae; Jisook Park; Jingi Bae; Eun-Bi Go; Su-Jin Kim; Hokeun Kim; Daehee Hwang; Sang-Won Lee; Soo-Youn Lee
Journal:  Mol Cell Proteomics       Date:  2016-09-06       Impact factor: 5.911

3.  Prenatal diagnosis in factor XIII-A deficiency.

Authors:  C J Killick; C J Barton; S Aslam; G Standen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

Review 4.  Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.

Authors:  Alisa S Wolberg; Yaqiu Sang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-06-02       Impact factor: 10.514

5.  Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus.

Authors:  Anthony W Ryan; David A Hughes; Kun Tang; Dermot P Kelleher; Thomas Ryan; Ross McManus; Mark Stoneking
Journal:  Eur J Hum Genet       Date:  2008-08-20       Impact factor: 4.246

6.  Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain.

Authors:  T Hashiguchi; A Ichinose
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  Genetic Factors Influencing Coagulation Factor XIII B-Subunit Contribute to Risk of Ischemic Stroke.

Authors:  Ken B Hanscombe; Matthew Traylor; Pirro G Hysi; Stephen Bevan; Martin Dichgans; Peter M Rothwell; Bradford B Worrall; Sudha Seshadri; Cathie Sudlow; Frances M K Williams; Hugh S Markus; Cathryn M Lewis
Journal:  Stroke       Date:  2015-07-09       Impact factor: 7.914

8.  Factor XIII B subunit polymorphisms and the risk of coronary artery disease.

Authors:  Zoltán A Mezei; Zsuzsanna Bereczky; Éva Katona; Réka Gindele; Emília Balogh; Szilvia Fiatal; László Balogh; István Czuriga; Róza Ádány; István Édes; László Muszbek
Journal:  Int J Mol Sci       Date:  2015-01-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.